As FDA Delays Novavax' COVID Vaccine Approval, Patients Fight Back

FDA Poised to Approve New COVID Vaccine

Vaccine maker Novavax announced that its COVID-19 vaccine is nearing full approval from the FDA. “We believe that our Biologics License Application (BLA) is approvable,” Novavax said in a statement, noting they look forward to engaging with the FDA expeditiously to address the PMC [postmarketing commitment] request and move to approval as soon as possible.” According to the Associated Press, the announcement raised the company’s stock by 21%. Th…

Novavax COVID Vaccine Moves Closer to Full FDA Approval

Key Takeaways

Novavax COVID vaccine moves closer to full FDA approval

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday.

After delays, Novavax Covid vaccine is on track for full FDA approval

Rejoice, fellow vaccine enthusiasts—it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, highly effective, Matrix-M adjuvanted, protein-based, non-mRNA COVID-19 vaccine, which also has the fewest side effects, to boot. The company announced yesterday that, after some delays that spurred patients and consumers to double down on their advocacy efforts, the COVID-19 Novavax vaccine looks to be on track to move fr…

Novavax Covid Vaccine Nears FDA Approval

Novavax could soon be added to the list of Covid vaccines granted full licensure — even as public trust in these products continues to erode. ... The post Novavax Covid Vaccine Nears FDA Approval appeared first on The New American.

As FDA delays Novavax' COVID vaccine approval, patients fight back

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F. Kennedy Jr cast doubt on its efficacy.